A Peroxodiiron(III/III) Intermediate Mediating Both N-Hydroxylation Steps in Biosynthesis of the N-Nitrosourea Pharmacophore of Streptozotocin by the Multi-domain Metalloenzyme SznF
- 23 June 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 142 (27), 11818-11828
- https://doi.org/10.1021/jacs.0c03431
Abstract
The alkylating warhead of the pancreatic cancer drug streptozotocin (SZN) contains an N-nitrosourea moiety constructed from Nω-methyl-l-arginine (l-NMA) by the multi-domain metalloenzyme SznF. The enzyme’s central heme-oxygenase-like (HO-like) domain sequentially hydroxylates Nδ and Nω′ of l-NMA. Its C-terminal cupin domain then rearranges the triply modified arginine to Nδ-hydroxy-Nω-methyl-Nω-nitroso-l-citrulline, the proposed donor of the functional pharmacophore. Here we show that the HO-like domain of SznF can bind Fe(II) and use it to capture O2, forming a peroxo-Fe2(III/III) intermediate. This intermediate has absorption- and Mössbauer-spectroscopic features similar to those of complexes previously trapped in ferritin-like diiron oxidases and oxygenases (FDOs) and, more recently, the HO-like fatty acid oxidase UndA. The SznF peroxo-Fe2(III/III) complex is an intermediate in both hydroxylation steps, as shown by the concentration-dependent acceleration of its decay upon exposure to either l-NMA or Nδ-hydroxy-Nω-methyl-l-Arg (l-HMA). The Fe2(III/III) cluster produced upon decay of the intermediate has a small Mössbauer quadrupole splitting parameter, implying that, unlike the corresponding product states of many FDOs, it lacks an oxo-bridge. The subsequent decomposition of the product cluster to one or more paramagnetic Fe(III) species over several hours explains why SznF was previously purified and crystallographically characterized without its cofactor. Programmed instability of the oxidized form of the cofactor appears to be a unifying characteristic of the emerging superfamily of HO-like diiron oxidases and oxygenases (HDOs).Funding Information
- Division of Chemistry (CHE-1610676)
- Harvard University
- Research Corporation for Science Advancement
- Camille and Henry Dreyfus Foundation
- National Institute of General Medical Sciences (GM105434, GM119707, GM127079, GM132564)
This publication has 53 references indexed in Scilit:
- Dioxygen Activation in Soluble Methane MonooxygenaseAccounts of Chemical Research, 2011
- Four-electron oxidation of p -hydroxylaminobenzoate to p -nitrobenzoate by a peroxodiferric complex in AurF from Streptomyces thioluteusProceedings of the National Academy of Sciences, 2010
- Revisiting the Mechanism of Dioxygen Activation in Soluble Methane Monooxygenase from M. capsulatus (Bath): Evidence for a Multi-Step, Proton-Dependent Reaction PathwayBiochemistry, 2009
- A Long-Lived, Substrate-Hydroxylating Peroxodiiron(III/III) Intermediate in the Amine Oxygenase, AurF, from Streptomyces thioluteusJournal of the American Chemical Society, 2009
- Human deoxyhypusine hydroxylase, an enzyme involved in regulating cell growth, activates O 2 with a nonheme diiron centerProceedings of the National Academy of Sciences, 2009
- Characterization of the Arene-Oxidizing Intermediate in ToMOH as a Diiron(III) SpeciesJournal of the American Chemical Society, 2007
- Large Kinetic Isotope Effects in Methane Oxidation Catalyzed by Methane Monooxygenase: Evidence for C−H Bond Cleavage in a Reaction Cycle IntermediateBiochemistry, 1996
- Mechanism of Assembly of the Tyrosyl Radical-Diiron(III) Cofactor of E. Coli Ribonucleotide Reductase: 1. Moessbauer Characterization of the Diferric Radical PrecursorJournal of the American Chemical Society, 1994
- Mechanism of Assembly of the Tyrosyl Radical-Diiron(III) Cofactor of E. coli Ribonucleotide Reductase. 2. Kinetics of The Excess Fe2+ Reaction by Optical, EPR, and Moessbauer SpectroscopiesJournal of the American Chemical Society, 1994
- Mechanism of Assembly of the Tyrosyl Radical-Dinuclear Iron Cluster Cofactor of Ribonucleotide ReductaseScience, 1991